---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-055985"
form_type: "8-K"
ticker: "KZR"
cik: "0001645666"
company_name: "Kezar Life Sciences, Inc."
filed_at: "2023-10-27T23:59:59+00:00"
generated_at: "2026-06-09T07:04:54.833164+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Kezar Life Sciences enters separation agreement with former CMO Noreen Roth Henig

## Summary
- Dr. Henig stepped down as CMO effective Oct 6, 2023; separation agreement signed Oct 23, 2023.
- Cash severance: 12 months base salary plus 40% of target bonus, paid over 12 months.
- Reimbursement of up to 12 months of COBRA premiums; vested stock option exercise extended to Dec 31, 2024.
- Severance contingent on a general release of claims effective Oct 31, 2024.

## SEC filing metadata
- accession: 0000950170-23-055985
- form_type: 8-K
- ticker: KZR
- cik: 0001645666
- company_name: Kezar Life Sciences, Inc.
- filed_at: 2023-10-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645666/000095017023055985/0000950170-23-055985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645666/000095017023055985/kzr-20231023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-055985
- JSON: https://secwatch.observer/filing/0000950170-23-055985.json
- Plain text: https://secwatch.observer/filing/0000950170-23-055985.txt

## Key facts
- Executive change
  Noreen Roth Henig departed as Chief Medical Officer at Kezar Life Sciences, Inc..
  - Action: stepped down
  - Role: Chief Medical Officer
  source text: On September 30, 2023, as previously announced, the board of directors of Kezar Life Sciences, Inc. (the “Company”) and Noreen Roth Henig, M.D., the Company’s former Chief Medical Officer, reached the mutual decision for Dr. Henig to step down as Chief Medical Officer effective October 6, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645666/000095017023055985/0000950170-23-055985-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.